07/03/2022

Giovannelli e Associati advised Neopharmed Gentili on their acquisition of lormetazepam product portfolio

Neopharmed Gentili, a pharmaceutical company specialized in the marketing of high therapeutic value solutions controlled by Ardian together with the Del Bono family, has entered into […]
07/03/2022

Legalcommunity Finance Awards 2022: Valerio Fontanesi of Giovannelli e Associati awarded for the category Thought leadership

Giovannelli e Associati is extremely proud to share that Valerio Fontanesi has been awarded for the Legalcommunity Finance Awards 2022 for the following category: Thought leadership. […]
03/03/2022

Giovannelli e Associati with Taste of Italy on the investment of EC I in Turatti

Giovannelli e Associati assisted Taste of Italy on the investment of EC I, a fund managed by Entangled Capital SGR., in the share capital of Turatti […]
22/02/2022

Giovannelli e Associati ranked again in Chambers Global 2022

We are proud to share that we have been ranked again in Chambers Global 2022 for Corporate/M&A.  Alessandro Giovannelli and Fabrizio Scaparro are also ranked as […]